Core Viewpoint - The recent updates from the company focus on the performance guidance for the fiscal year 2025 and operational status, with no new significant events announced [1]. Group 1: Performance and Operational Situation - The company reaffirmed its fiscal year 2025 performance guidance, projecting revenue between $4.65 billion and $4.85 billion, adjusted EBITDA guidance of $1.175 billion to $1.225 billion, and free cash flow expectations of $550 million to $600 million [2]. - The backlog of orders reached a record $5.14 billion in the first quarter of 2025, indicating robust demand for orders [2]. Group 2: Company Performance Goals - The company emphasized its mid-term development goals, including an organic revenue growth rate in the mid-teens, a gross margin level around 30%, and a target to reduce net leverage to a range of 2.0 to 2.5 times [3]. - The information is primarily sourced from public reports between March and May 2025, with no recent financial disclosures or future event plans announced as of February 11, 2026 [3].

Core Viewpoint - Estée Lauder (EL.US) experienced a nearly 20% drop in stock price following the release of its Q2 FY2026 earnings, despite a 44% increase over the past year, currently trading at $96.49 [1] Financial Performance - The company reported Q2 sales of $4.23 billion, meeting analyst expectations [1] - Adjusted earnings per share (EPS) were $0.89, surpassing the forecast of $0.83 [1] Future Guidance - The company increased marketing expenditures for brand revitalization while facing cost pressures from tariffs, which are compressing profit margins and affecting annual profit expectations [1] - Full-year net sales growth guidance is set at 3% to 5%, with a midpoint of 4%, which is below the analyst expectation of 4.3% [1] - Adjusted EPS guidance is projected between $2.05 and $2.25, with a midpoint of $2.15, also falling short of the anticipated $2.16 [1]

Core Insights - The company reported a global revenue of $19.292 billion for the year 2025, representing a 43% increase compared to $13.533 billion in 2024, driven primarily by the sales growth of Mounjaro and Zepbound [1] - The net profit according to GAAP was $6.636 billion, a 50% year-over-year increase, with earnings per share (EPS) of $7.39, also reflecting a 51% increase, including $0.52 in IPR&D expenses [1] - Non-GAAP net profit was $6.771 billion, a 41% increase year-over-year, with an EPS of $7.54, marking a 42% increase, similarly including $0.52 in IPR&D expenses [1] - The company provided guidance for 2026, expecting revenue to reach between $80 billion and $83 billion, with non-GAAP EPS projected at $33.50 to $35.00 [1]

Core Viewpoint - Boston Scientific (BSX.US) experienced a significant drop of over 15%, marking its largest intraday decline since March 2020, currently trading at $77.80 [1] Financial Guidance - The company provided its fiscal year 2026 earnings guidance, projecting adjusted earnings per share between $3.43 and $3.49, slightly below the analysts' average expectation of $3.47 [1] - The expected annual sales range is between $22.181 billion and $22.383 billion, which is lower than the analysts' average forecast of $22.368 billion [1]

周三，礼来(LLY.US)盘前涨超8%，报1085.30美元。消息面上，该公司公布了四季度营收、利润及2026 年业绩指引均大幅超出市场预期的财报。礼来四季度营收为192.9亿美元，较上年同期大涨43%，远高 于分析师预期的179.6亿美元。其中，美国市场营收达129亿美元，礼来表示，这主要得益于旗下产品 (尤其是Mounjaro和Zepbound)销量(即处方量或销售数量)激增50%，部分抵消了这些药物实际价格的下 降。 展望未来，这家制药巨头预计，2026年全年营收将在800亿至830亿美元之间，分析师预期为776.2亿美 元。利润方面，礼来预计2026年调整后每股收益为33.50至35美元，而分析师普遍预期为33.23美元。 礼来四季度实现净利润66.4亿美元，合每股收益7.39美元;而上年同期公司净利润为44.1亿美元，合每股 收益4.88美元。剔除与无形资产估值相关的一次性项目及其他调整项后，礼来四季度调整后每股收益为 7.54美元，高于市场预期的6.67美元。 ...

Group 1 - The core viewpoint of the article is that Mondelez International (MDLZ.US) reported solid fourth-quarter results, but the stock fell 4.5% in pre-market trading due to lower-than-expected future growth projections [1] Group 2 - Mondelez's adjusted earnings per share (EPS) for the fourth quarter was $0.72, representing an 11% year-over-year increase, exceeding market expectations of $0.70 [1] - The company's revenue reached $10.5 billion, a 9% year-over-year growth, surpassing expectations by $207 million [1] - Management forecasts organic sales growth to stabilize at +2% by 2026, with adjusted EPS growth (at constant currency) expected to remain at +5%, both below long-term targets of 3%-5% and high single-digit growth [1]

诺和诺德首席执行官：2026年业绩指引的原因"实际上与价格下跌有关"。 来源：滚动播报 ...

Core Insights - Avnet, Inc. (AVT) shares increased by 13.8% following the release of better-than-expected second-quarter fiscal 2026 results, with adjusted earnings of $1.05 per share exceeding the Zacks Consensus Estimate by 10.53% and showing a year-over-year increase of 20.7% [1][10] Financial Performance - Net sales rose by 11.6% year over year to $6.32 billion, surpassing the consensus estimate by 5.28%, driven by strong performance across operating segments [2][10] - The Electronic Components segment's revenue increased by 10.8% year over year to $5.89 billion, exceeding the estimate of $5.6 billion [3] - Farnell sales surged by 23.6% year over year to $427.1 million, outperforming the estimate of $400.8 million [3] Regional Sales Performance - Year-over-year sales growth included a 16.9% increase in Asia to $3.17 billion, a 4.9% increase in the Americas to $1.44 billion, and an 8.3% increase in EMEA to $1.71 billion [4] Operating Income and Margins - Adjusted operating income was $171.7 million, a 7.7% increase year over year, with the Electronic Components segment's operating income rising 3% to $187.1 million [4] - The adjusted operating margin decreased by 10 basis points to 2.7%, with the Electronic Components margin contracting by 20 basis points to 3.2%, while Farnell's margin improved by 370 basis points to 4.7% [5] Balance Sheet and Cash Flow - As of December 27, 2025, cash and cash equivalents were $286.5 million, up from $175.5 million as of September 27, 2025, while long-term debt decreased to $2.47 billion from $2.79 billion [6] - Operating cash flow for the second quarter was $208 million, with $28 million paid in dividends and $138.3 million in share repurchases during the first half of fiscal 2026 [7] Future Guidance - For the third quarter of fiscal 2026, Avnet expects revenues between $6.2 billion and $6.5 billion, with a midpoint of $6.35 billion, indicating a year-over-year increase of 9.1% [8] - Non-GAAP earnings are anticipated to be between $1.20 and $1.30 per share, with the consensus estimate at $1.22, suggesting a year-over-year increase of 45.2% [8]

美股周五盘前，英特尔（Intel）股价下跌13%。此前该公司公布的第四季度业绩表现好坏不一，且对当 前季度（三个月）的业绩指引逊于预期。 美股周五盘前，英特尔（Intel）股价下跌13%。此前该公司公布的第四季度业绩表现好坏不一，且对当 前季度（三个月）的业绩指引逊于预期。 根据伦敦证券交易所集团数据，该公司调整后每股收益为15美分，高于分析师普遍预期的8美分；但营 收未达预期，录得137亿美元，低于市场预估的134亿美元。英特尔还表示第一季度无法满足季节性需求 所需的供应量，令投资者失望。 责任编辑：张俊 SF065 根据伦敦证券交易所集团数据，该公司调整后每股收益为15美分，高于分析师普遍预期的8美分；但营 收未达预期，录得137亿美元，低于市场预估的134亿美元。英特尔还表示第一季度无法满足季节性需求 所需的供应量，令投资者失望。 责任编辑：张俊 SF065 ...

Group 1 - President Trump indicated that Iran is interested in engaging with the U.S., suggesting a potential restoration of diplomatic communication [1] - Trump filed a lawsuit against JPMorgan Chase and CEO Jamie Dimon for at least $5 billion, claiming the defendants ceased banking services for political reasons [2] - European super-rich investors are considering reducing investments in the U.S. due to Trump's controversial actions [3] Group 2 - Elon Musk made a surprise appearance at the Davos Forum, announcing plans to publicly sell humanoid robots by the end of this year or next [4] - Intel reported fourth-quarter earnings that exceeded Wall Street expectations, but provided a weak earnings guidance for Q1 2026, leading to a 10% drop in after-hours trading [5] - Apple has integrated design responsibilities into hardware chief John Ternus's role, solidifying his position as a leading candidate to succeed CEO Tim Cook [6] Group 3 - Bank of America and Citigroup are exploring various options to accommodate Trump's request to cap credit card interest rates at 10% for one year [7] - Spot gold prices increased by 2.22%, reaching a historic high of $4,939.41 per ounce [8] - Raymond James upgraded its rating from outperform to strong buy, raising the target price from $315 to $400 [9]